In patients with non-squamous NSCLC, 10 had EGFR mutant tumors, 23 had no G12C KRAS mutated tumors, and 15 had G12C KRAS mutated tumors, whereas 67 patients were considered as WT, i.e., non-KRAS and non-EGFR mutated tumors. Here, KRAS is linked to non-small cell lung carcinoma.